Mpox can have a devastating impact on people with advanced cases of HIV, leading to severe skin and genital lesions and causing death in as many as 1 in 4 of those with a highly compromised immune ...

In a recent study published in The Lancet, researchers assessed the incidence of mpox in individuals with advanced human immunodeficiency virus (HIV) infection. In July 2022, the World Health ...

DENVER — Studies published in a medical journal and presented at a conference showed that tecovirimat did not increase clinical resolution of mpox and may contribute to antiviral resistance for people ...

Please provide your email address to receive an email when new articles are posted on . The incidence of Kaposi’s sarcoma and related death in East Africa has not improved in the last 5 years. In a ...

A global case series described a severe form of mpox linked to a 15% mortality rate among people living with HIV and low CD4 counts. An international network of clinicians have discovered a severe, ...

due at least in part to weakened immune defenses against the common sexually transmitted human papillomavirus (HPV). The research findings by scientists at the University of California, San Francisco ...

A diagnosis of Kaposi sarcoma is a significant life event, but it is a manageable condition. Because KS is so closely linked to immune function, your treatment will likely involve a collaborative ...